Home Tags Hepatocellular carcinoma

Tag: hepatocellular carcinoma

NanoValent Receives NIH SBIR Funding for Ongoing Development of Antibody-conjugated Nanoparticle...

The National Institute of Health's (NIH) Small Business Innovation Research (SBIR) Program has confirmed that it has awarded first year funding for two separate...

Compugen’s Antibody Drug Conjugate Program Results Presented

This week, during the World ADC Summit being held October 19 - 22, 2015 in San Diego, CA, Compugen presented the status of its predictive...

Company Files Novel Antibody-Drug Conjugate Patent Application

Earlier this year, Woonsocket, Rhode Island, based MultiCell Technologies, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools for the treatment of neurological disorders,...